Mercator Medical S.A. (WSE:MRC)
Poland flag Poland · Delayed Price · Currency is PLN
57.60
+0.10 (0.17%)
Sep 4, 2026, 5:00 PM CET

Mercator Medical Cash Flow Statement

Millions PLN. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
12.328.5944.63-19.68-189.62446.87
Depreciation & Amortization
25.4123.9918.7919.6624.0118.38
Other Amortization
4.724.794.522.461.660.93
Loss (Gain) From Sale of Assets
-3.3-3.24-0.330.896.070.38
Asset Writedown & Restructuring Costs
-5.17-5.03-55.5714.2127.52-
Loss (Gain) From Sale of Investments
1.021.05----
Stock-Based Compensation
-----0.02
Other Operating Activities
-12.53-33.96-2.87-93.499.38-122.61
Change in Accounts Receivable
-6.9714.13-24.65-12.2274.08191.38
Change in Inventory
51.0421.84-65.0952.9129.74-23.4
Change in Other Net Operating Assets
3.92-14.6714.5535.18-42.04-8.94
Operating Cash Flow
70.4437.49-66.02-0.0940.79503
Operating Cash Flow Growth
-----91.89%-29.40%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-55.74-50.94-18.72-39.07-109.65-176.75
Sale of Property, Plant & Equipment
5.655.540.660.620.350.16
Investment in Securities
36.3653.236.3163.82-4.11-53.84
Other Investing Activities
22.5323.254.688.229.480.39
Investing Cash Flow
-27.51-5.47-12.8833.59-146.74-230.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.02----
Long-Term Debt Issued
----0.21-
Total Debt Issued
00.02--0.21-
Short-Term Debt Repaid
------0.72
Long-Term Debt Repaid
--1.75-0.9-0.74-1.58-1.74
Total Debt Repaid
-2.04-1.75-0.9-0.74-1.58-2.46
Net Debt Issued (Repaid)
-2.04-1.73-0.9-0.74-1.37-2.46
Issuance of Common Stock
-----0.75
Repurchase of Common Stock
-12.45-12.45-14.95-16.27--332.08
Common Dividends Paid
----23.87--
Other Financing Activities
-0.5-0.44-0.23-0.19-0.02-0.12
Financing Cash Flow
-14.99-14.62-16.08-41.07-1.39-333.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
00.282.020.2-8.930.72
Net Cash Flow
27.9417.68-92.96-7.37-116.26-60.23

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
14.7-13.45-84.75-39.15-68.86326.25
Free Cash Flow Growth
------53.19%
Free Cash Flow Margin
2.57%-2.34%-15.62%-8.34%-12.69%18.87%
Free Cash Flow Per Share
1.60-1.46-9.03-4.08-7.0532.23
Levered Free Cash Flow
88.9744.86-110.05-27.59-100.51195.43
Unlevered Free Cash Flow
89.345.16-109.84-27.07-100.3195.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.50.440.230.190.020.12
Cash Income Tax Paid
0.760.793.590.5229.93119.99
Change in Working Capital
47.9921.3-75.1975.8861.77159.04